Vanguard’s Biggest Bond ETF Becomes First to Break $100 Billion

Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal 

With Yields Above 5%, Some Investors Say It's Safe to Start Buying Bonds Again